Clinical Trials for GenSight Biologics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: GenSight Biologics

Clinical Trials (1)

NCT03326336
Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa
PHASE1/PHASE2Active, not recruiting
10 participants
Started: Sep 26, 2018 · Completed: Oct 26, 2027
1 condition1 sponsor3 locations